Merritt, Christopher

Merritt, Christopher was paid $1.26M by Medicaid between Mar 2018 and Dec 2024, across 6 billing codes. Its largest line is 99283, emergency room visit (moderate) — 61% of everything it billed.

33Billing provider infoMERRITT, CHRISTOPHER
BOSTON, MA 02118

33aNPI1174660211assigned 01/30/2007

33bProvider typePediatric Emergency Medicine (Pediatrics) Physician

28Total paid$1.26M

24GClaims7,739

24DCodes billed6

24AFirst – last monthMar 2018 – Dec 2024

Compared with peers

Next to other Pediatric Emergency Medicine (Pediatrics) Physician providers in Massachusetts

Rank by total paid#2 of 38

Median peer was paid$13K

This provider vs. median100×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	796	$65K
2019	673	$79K
2020	662	$100K
2021	1,464	$270K
2022	1,616	$291K
2023	1,249	$216K
2024incomplete	1,279	$234K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	61%	4,213	4,078	$765K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	22%	2,235	2,184	$275K
99282	Emergency department visit for the evaluation and management, low to moderate severity	12%	865	807	$147K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.2%	389	383	$66K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	25	25	$3K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	12	12	$352.50

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.